Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5199030
Max Phase: Preclinical
Molecular Formula: C20H27FN2S
Molecular Weight: 346.52
Associated Items:
ID: ALA5199030
Max Phase: Preclinical
Molecular Formula: C20H27FN2S
Molecular Weight: 346.52
Associated Items:
Canonical SMILES: CN(Cc1ccsc1)CC1CCN(CCc2cccc(F)c2)CC1
Standard InChI: InChI=1S/C20H27FN2S/c1-22(15-19-8-12-24-16-19)14-18-6-10-23(11-7-18)9-5-17-3-2-4-20(21)13-17/h2-4,8,12-13,16,18H,5-7,9-11,14-15H2,1H3
Standard InChI Key: QPSUWJDLXVUKCT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 346.52 | Molecular Weight (Monoisotopic): 346.1879 | AlogP: 4.27 | #Rotatable Bonds: 7 |
Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.31 | CX LogP: 4.34 | CX LogD: 1.48 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: -2.46 |
1. Woolard KJ, Sandala JL, Melander RJ, Gunn JS, Melander C.. (2022) Development of small molecules that work cooperatively with ciprofloxacin to clear salmonella biofilms in a chronic gallbladder carriage model., 232 [PMID:35219950] [10.1016/j.ejmech.2022.114203] |
Source(1):